FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a selective thiazolidinedione analogue to be used in treating and preventing diabetes and dyslipidemia, representing 5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione or a pharmaceutically acceptable salt thereof. Also, the invention refers to a pharmaceutical composition for diabetes and dyslipidemia, containing an effective amount of 5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione or the pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 
.
EFFECT: what is produced is the selective thiazolidinedione analogue decreasing binding and activating of the PPARγ nuclear transcription factor.
4 cl, 2 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
| NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
| SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
| PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
| PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
| METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
| METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
| THIAZOLIDINEDIONE ANALOGUES | 2007 |
|
RU2445957C2 |
| MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
| HETEROCYCLIC MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTER | 2006 |
|
RU2463303C2 |
